No deleterious effect of low dose methotrexate on titanium implant osseointegration in a rabbit model

Carvas, João Miguel; Pereira, Rosa Maria Rodrigues; Bonfá, Eloísa; Silveira, Celey Aparecida; Lima, Luiz Lapa; Caparbo, Valéria F.; Mello, Suzana Beatriz Verissímo de

doi:10.1590/s1807-59322011000600023

Cited by 9 publications

(6 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Carvas et al . [ 16 ] evaluated the osseointegratiom process in a rabbit model during an 18-week period. Groups of 6-8 rabbits were treated with saline, methotrexate, glucocorticoid, or methotrexate plus glucocorticoid and received implants after 6 weeks.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of Effect of Low-Dose Methotrexate on Osseointegration of Implants: A Biomechanical Study on Dogs

Tavakoli¹,

Yaghini²,

Abed³

et al. 2018

TODENTJ

View full text Add to dashboard Cite

Background:Methotrexate (MTX) is an immunosuppressive drug, widely used in inflammatory disturbances including rheumatoid arthritis. However, there is no consensus regarding the effect of MTX on implant osseointegration.Objective:The purpose of this experimental study was to investigate the effect of low dose MTX on Bone-Implant Contact (BIC) of dogs.Methods:Six mandibular premolar teeth (bilateral) of 8 mature dogs were extracted. After 3 months of healing, 6 implants (bone level, resorbable blast media surface) were inserted into the mandible of each dog (3 in each side). Dogs were randomly divided into a study group (receiving 2.5 mg/week MTX orally, 3 times per week for 4 weeks) and a control group each containing 4 dogs. In the 1st week, postoperative BIC was evaluated in 4 dogs, two from each group. In the 4th week, reverse torque and BIC were evaluated in the remaining 4 dogs. Data were analyzed with two-way ANOVA test for 95% confidence interval.Results:The reverse torque test of the 4th week, showed a satisfying osseointegration. Histopathologic evaluation revealed that the BIC was significantly higher in the control group in comparison to the MTX group in the 1st and 4th week. In addition, the BIC of both groups were significantly increased in the 4th week in comparison to the 1st week in both groups.Conclusion:MTX has the potential to interfere with osseointegration process.

show abstract

Section: Discussionmentioning

confidence: 99%

“…However, Carvas et al . found no deleterious effect of MTX on osseointegration of implants inserted in the tibia of a rabbit model [ 16 ].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Effect of Low-Dose Methotrexate on Osseointegration of Implants: A Biomechanical Study on Dogs

Tavakoli¹,

Yaghini²,

Abed³

et al. 2018

TODENTJ

View full text Add to dashboard Cite

show abstract

“…In a study using a canine model, a low-dose MTX reduced bone-to-implant contact (BIC), although osseointegration of inserted implant was acceptable (Tavakoli et al, 2018). On the other hand, another study demonstrated that cortical thickness, total bone area and BIC were not significantly different between the control and MTX groups in a rabbit model (Carvas et al, 2011). In a retrospective case series analyzing implant treatment in patients with RA and connective tissue disease (CTD), 13 implants were inserted in patients receiving MTX, and they all survived (Weinlander et al, 2010) (Table 4).…”

Section: Methotrexatementioning

confidence: 99%

Effect of agents affecting bone homeostasis on short‐ and long‐term implant failure

Jung,

Ryu,

Shim

et al. 2023

Clinical Oral Implants Res

View full text Add to dashboard Cite

ObjectivesTo review the current evidence on the relationship between agents that affect bone homeostasis and dental implant failures.Materials and MethodsElectronic searches for bisphosphonates, denosumab, methotrexate, corticosteroids, romosozumab, sunitinib, and bevacizumab were performed using PubMed, MEDLINE (OVID), EMBASE (OVID), Cochrane Central Register of Controlled Trials (Cochrane Library), Cochrane Oral Health Group Trials Register (Cochrane Library) and Web of Science (Thomson Reuters). Manual searches were also conducted to complement the digital searches for recent issues.ResultsPrevious publications suggested that bisphosphonates do not compromise the survival of dental implants. However, one study documented an increased risk of implant failure in patients who had received high‐dose of intravenous bisphosphonate therapy after implant rehabilitation. There has been an issue of MRONJ around implants in patients who have successfully received implant therapy before and after antiresorptive therapy, leading to late implant failure. Despite evidence on the detrimental effects of denosumab, methotrexate and corticosteroids on bone metabolism, their role in implant survival is not conclusive.ConclusionsAt present, there is insufficient evidence to establish a potential connection between agents that affects bone homeostasis and implant failure. However, some studies have reported negative results for implant therapy. In addition, implant‐related sequestration in patients who received anti‐resorptive therapy, despite of successful osseointegration, is also noticeable. Although limited studies are available at present, clinicians should still carefully consider the potential hazards and take appropriate precautions to minimize the risks associated with the medications and implant therapy.

show abstract

“…Such a medication cocktail may prevent osseointegration and bone repair processes. 334 There is no significant risk factor for implant osseointegration in RA patients despite the apparent ability of RA medications to interfere with it. 335 Consequently, dental implants are not contraindicated by RA.…”

Section: Rheumatoid Arthritismentioning

confidence: 99%

Dental implant considerations in patients with systemic diseases: An updated comprehensive review

Mosaddad,

Talebi,

Keyhan

et al. 2024

J of Oral Rehabilitation

View full text Add to dashboard Cite

BackgroundVarious medical conditions and the drugs used to treat them have been shown to impede or complicate dental implant surgery. It is crucial to carefully monitor the medical status and potential post‐operative complications of patients with systemic diseases, particularly elderly patients, to minimize the risk of health complications that may arise.AimThe purpose of this study was to review the existing evidence on the viability of dental implants in patients with systemic diseases and to provide practical recommendations to achieve the best possible results in the corresponding patient population.MethodsThe information for our study was compiled using data from PubMed, Scopus, Web of Science and Google Scholar databases and searched separately for each systemic disease included in our work until October 2023. An additional manual search was also performed to increase the search sensitivity. Only English‐language publications were included and assessed according to titles, abstracts and full texts.ResultsIn total, 6784 studies were found. After checking for duplicates and full‐text availability, screening for the inclusion criteria and manually searching reference lists, 570 articles remained to be considered in this study.ConclusionIn treating patients with systemic conditions, the cost–benefit analysis should consider the patient's quality of life and expected lifespan. The success of dental implants depends heavily on ensuring appropriate maintenance therapy, ideal oral hygiene standards, no smoking and avoiding other risk factors. Indications and contraindications for dental implants in cases of systemic diseases are yet to be more understood; broader and hardcore research needs to be done for a guideline foundation.

show abstract

No deleterious effect of low dose methotrexate on titanium implant osseointegration in a rabbit model

Cited by 9 publications

References 26 publications

Evaluation of Effect of Low-Dose Methotrexate on Osseointegration of Implants: A Biomechanical Study on Dogs

Evaluation of Effect of Low-Dose Methotrexate on Osseointegration of Implants: A Biomechanical Study on Dogs

Effect of agents affecting bone homeostasis on short‐ and long‐term implant failure

Dental implant considerations in patients with systemic diseases: An updated comprehensive review

Contact Info

Product

Resources

About